Use of the progesterone (P4) receptor antagonist aglepristone to characterize the role of P4 withdrawal for parturition and placental release in cows

dc.contributor.authorShenavai, Sima
dc.contributor.authorHoffmann, Bernd
dc.contributor.authorDilly, Marc
dc.contributor.authorPfarrer, Christiane D.
dc.contributor.authorSchüler, Gerhard
dc.contributor.buuauthorÖzalp, Gözde Rabia
dc.contributor.buuauthorÇalışkan, Çağlar
dc.contributor.buuauthorSeyrek İntaş, Kamil
dc.contributor.departmentUludağ Üniversitesi/Veterinerlik Fakültesi/Doğum ve Jinekoloji Bölümü.tr_TR
dc.contributor.orcid0000-0003-4694-6937tr_TR
dc.contributor.researcheridAAH-7292-2019tr_TR
dc.contributor.researcheridAAE-3607-2019tr_TR
dc.contributor.scopusid23985710500tr_TR
dc.contributor.scopusid23984353800tr_TR
dc.contributor.scopusid6603409870tr_TR
dc.date.accessioned2022-08-18T07:49:02Z
dc.date.available2022-08-18T07:49:02Z
dc.date.issued2010-10
dc.description.abstractIn late pregnant cows, progesterone (P-4) is mainly of luteal origin. However, the trophoblast may provide high local P-4 concentrations in the uterus. To test for the importance of a complete P-4 withdrawal for parturition-related processes and placental release, the P-4 receptor (PGR) blocker aglepristone (Ap) was administered to three cows on days 270 and 271 of pregnancy. A complete opening of the cervix was observed 46.5 +/- 7.3 h after the start of treatment. However, expulsion of the calves was impaired obviously because of insufficient myometrial activity, and placental membranes were retained for at least 10 days. Measurement of P-4 concentrations indicated that PGR blockage induced luteolysis. To investigate the role of P-4 withdrawal for the prepartal tissue remodeling of the placentomes, the caruncular epithelium was evaluated by morphometry, and the percentage of trophoblast giant cells (TGCs) relative to the total number of trophoblast cells were assessed. Caruncular epithelium in Ap-treated cows (D272 + Ap) was immature (30.5 +/- 3.3%) and not different from untreated controls (elected cesarean section (CS) on day 272; D272-CS; 31.5 +/- 1.4%), whereas it was significantly reduced at normal term (D280.5 +/- 1.3; 21.0 +/- 6.1%; P=0.011). Correspondingly, the percentage of TGCs were 20.1 +/- 1.4 in D272 + Ap, 22.1 +/- 4.8 in D272-CS, and 9.8 +/- 3.9 at term (P=0.001). No effect was detected on placental estrogen synthesis. The results showed that in late pregnant cows, P-4 withdrawal only induces a limited spectrum of the processes related to normal parturition and is not a crucial factor for the prepartal tissue remodeling in placentomes and the timely release of the placenta.en_US
dc.description.sponsorshipGerman Research Foundation (DFG) (SCHU1195/3-1)en_US
dc.identifier.citationShenavai, S. vd. (2010). "Use of the progesterone (P4) receptor antagonist aglepristone to characterize the role of P4 withdrawal for parturition and placental release in cows". Reproduction, 140(4), 623-632.en_US
dc.identifier.endpage632en_US
dc.identifier.issn1470-1626
dc.identifier.issue4tr_TR
dc.identifier.pubmed20621935tr_TR
dc.identifier.scopus2-s2.0-77957973988tr_TR
dc.identifier.startpage623tr_TR
dc.identifier.urihttps://doi.org/10.1530/REP-10-0182
dc.identifier.urihttps://rep.bioscientifica.com/view/journals/rep/140/4/623.xml?body=pdf-29090
dc.identifier.urihttp://hdl.handle.net/11452/28244
dc.identifier.volume140tr_TR
dc.identifier.wos000282645400013tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherBioscientificaen_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalReproductionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.relation.tubitakTOVAG 107O259tr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPregnancy-associated glycoproteinsen_US
dc.subjectRetained placentaen_US
dc.subjectInduced luteolysisen_US
dc.subjectHormonel changesen_US
dc.subjectBovine placentaen_US
dc.subjectFetalen_US
dc.subjectCattleen_US
dc.subjectInductionen_US
dc.subjectDexamethasoneen_US
dc.subjectCloprostenolen_US
dc.subjectDevelopmental biologyen_US
dc.subjectReproductive biologyen_US
dc.subject.emtreeAglepristoneen_US
dc.subject.emtreeAntigestagenen_US
dc.subject.emtreeEstradiolen_US
dc.subject.emtreeEstrogenen_US
dc.subject.emtreeHydrocortisoneen_US
dc.subject.emtreeProgesteroneen_US
dc.subject.emtreeProgesterone receptoren_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeAglepristoneen_US
dc.subject.emtreeDrug derivativeen_US
dc.subject.emtreeEstrane derivativeen_US
dc.subject.emtreeEstroneen_US
dc.subject.emtreeEstrone sulfateen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal tissueen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBirthen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCowen_US
dc.subject.emtreeEstrogen blood levelen_US
dc.subject.emtreeEstrogen synthesisen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHydrocortisone blood levelen_US
dc.subject.emtreeLuteolysisen_US
dc.subject.emtreeMorphometricsen_US
dc.subject.emtreeMyometriumen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePlacental deliveryen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeReceptor blockingen_US
dc.subject.emtreeRetained placentaen_US
dc.subject.emtreeTrophoblasten_US
dc.subject.emtreeUterine cervix dilatationen_US
dc.subject.emtreeUterus contractionen_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeAnimal diseaseen_US
dc.subject.emtreeBlooden_US
dc.subject.emtreeCattleen_US
dc.subject.emtreeCell counten_US
dc.subject.emtreeCytochemistryen_US
dc.subject.emtreeCytologyen_US
dc.subject.emtreeDrug antagonismen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreePhysiologyen_US
dc.subject.emtreePlacentaen_US
dc.subject.emtreePregnancyen_US
dc.subject.meshAnimalsen_US
dc.subject.meshCattleen_US
dc.subject.meshCell counten_US
dc.subject.meshEstradiolen_US
dc.subject.meshEstrenesen_US
dc.subject.meshEstroneen_US
dc.subject.meshFemaleen_US
dc.subject.meshHistocytochemistryen_US
dc.subject.meshParturitionen_US
dc.subject.meshPlacentaen_US
dc.subject.meshPregnancyen_US
dc.subject.meshProgesteroneen_US
dc.subject.meshReceptors, progesteroneen_US
dc.subject.scopusFetal Death; Mummification; Cloprostenolen_US
dc.subject.wosDevelopmental biologyen_US
dc.subject.wosReproductive biologyen_US
dc.titleUse of the progesterone (P4) receptor antagonist aglepristone to characterize the role of P4 withdrawal for parturition and placental release in cowsen_US
dc.typeArticle
dc.wos.quartileQ2en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Özalp_vd_2010.pdf
Size:
416.17 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: